Streetbeat News

Stock Prices

CCTS

VVPR

VivoPower International PLC (NASDAQ:VVPR) shares surged over 300% after announcing a stock buyback program and a merger between its Tembo subsidiary and Cactus Acquisition Corp. 1 Limited (NASDAQ:CCTS), with heavy trading volume. The stock's year-to-date gain is 120.19%, outperforming its historical averages, despite an RSI of 97.76 indicating overbought conditions.

Portfolio Pulse from Erica Kollmann

April 03, 2024 | 2:18 pm

JPM

Recent analysis of JPMorgan Chase (JPM) options trading reveals a bearish sentiment among big money investors, with a mix of bullish and bearish trades. The trading volume and open interest suggest a price target range between $140 and $210. Notable trades include both bullish and bearish calls with varying strike prices and expiration dates. JPMorgan Chase, a major financial institution, is currently trading at $198.99, with analysts setting an average price target of $203.8. The stock is potentially approaching overbought territory, with earnings expected in 9 days.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 2:16 pm

PLTR

Financial analysis reveals a bearish trend in options trading for Palantir Technologies (NYSE:PLTR), with 63% of trades showing bearish tendencies. The analysis of unusual trades found 19 instances, with a price target range from $10.0 to $35.0. The largest trades include both bullish and bearish sentiments, with significant volumes and open interests. Palantir's current trading volume is 5,398,222, with a slight price decrease of -0.44%, and an RSI indicating potential overselling. Analysts have mixed opinions, with target prices ranging from $20 to $35.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 2:16 pm

ELF

ULTA

e.l.f. Beauty's stock is trading lower following Ulta Beauty's issuance of weak guidance at a conference, indicating potential industry-wide concerns.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 2:13 pm

AFRM

AMZN

FCUS

IBUY

SHOP

Needham analyst Kyle Peterson initiated coverage on Affirm Holdings Inc (AFRM) with a Hold rating, citing valuation concerns, high stock-based compensation, and a significant portion of revenue from lending-related income. Despite Affirm's strong position in the BNPL market and potential for international expansion, these factors are expected to keep AFRM shares range-bound. Affirm's partnerships with Amazon (AMZN) and Shopify (SHOP) are highlighted, and investors can also gain exposure through ETFs FCUS and IBUY.

Portfolio Pulse from Anusuya Lahiri

April 03, 2024 | 2:06 pm

ABBV

FGEN

FibroGen Inc (NASDAQ:FGEN) released early data from a Phase 1 study of FG-3246 for prostate cancer, showing promising results. The study, sponsored by Fortis Therapeutics, indicated significant PSA reductions and partial responses in patients. Despite adverse events similar to other MMAE-based ADCs, the efficacy metrics are encouraging. William Blair suggests further exploration, noting plans to improve FG-3246's effectiveness, including a dosing scheme inspired by AbbVie Inc's (NYSE:ABBV) Elahere. FibroGen plans to consult with the FDA and start a Phase 2 study later this year. FGEN shares dropped 18.30% to $1.77.

Portfolio Pulse from Vandana Singh

April 03, 2024 | 2:02 pm

ABIO

ARCA Biopharma Inc (NASDAQ:ABIO) and Oruka Therapeutics have announced a merger in an all-stock transaction. The merged entity, to be named Oruka Therapeutics Inc and trade under the ticker ORKA, will focus on developing treatments for chronic skin diseases. Oruka has secured $275 million in private investment to support operations through 2027 and the development of its key programs, ORKA-001 and ORKA-002. The merger, expected to close in Q3 2024, will see pre-merger ARCA stockholders owning about 2.38% of the new company. ABIO shares soared 106.40% to $3.49 following the announcement.

Portfolio Pulse from Vandana Singh

April 03, 2024 | 2:00 pm

LSCC

Over the past 15 years, Lattice Semiconductor (NASDAQ:LSCC) has outperformed the market with an annualized return of 29.02%, turning a $100 investment into $5,028.19. The company now has a market capitalization of $10.11 billion.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 2:00 pm

TMUS

Over the past 10 years, T-Mobile US (NASDAQ:TMUS) has significantly outperformed the market, with an annualized return of 17.91%, turning a $1000 investment into $5,266.25. The company's market capitalization stands at $192.20 billion.

Portfolio Pulse from Benzinga Insights

April 03, 2024 | 2:00 pm

GE

GE Aerospace's stock is experiencing an uptick after the successful completion of the GE Vernova spin-off.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 2:00 pm